nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A4—Budesonide—ulcerative colitis	0.0582	0.134	CbGbCtD
Paliperidone—CYP3A5—Sulfasalazine—ulcerative colitis	0.0505	0.116	CbGbCtD
Paliperidone—CYP3A5—Hydrocortisone—ulcerative colitis	0.0405	0.0934	CbGbCtD
Paliperidone—CYP2D6—Nicotine—ulcerative colitis	0.0398	0.0917	CbGbCtD
Paliperidone—CYP2D6—Cholecalciferol—ulcerative colitis	0.0357	0.0823	CbGbCtD
Paliperidone—CYP3A4—Methylprednisolone—ulcerative colitis	0.026	0.0599	CbGbCtD
Paliperidone—CYP3A4—Nicotine—ulcerative colitis	0.0253	0.0583	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—ulcerative colitis	0.0252	0.0581	CbGbCtD
Paliperidone—CYP3A4—Cholecalciferol—ulcerative colitis	0.0227	0.0523	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—ulcerative colitis	0.0197	0.0454	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—ulcerative colitis	0.0169	0.0389	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—ulcerative colitis	0.0167	0.0384	CbGbCtD
Paliperidone—CYP3A4—Hydrocortisone—ulcerative colitis	0.0158	0.0364	CbGbCtD
Paliperidone—CYP3A4—Prednisone—ulcerative colitis	0.0158	0.0363	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—ulcerative colitis	0.0155	0.0356	CbGbCtD
Paliperidone—CYP3A4—Dexamethasone—ulcerative colitis	0.00983	0.0226	CbGbCtD
Paliperidone—Infection—Hydrocortisone—ulcerative colitis	0.000204	0.000508	CcSEcCtD
Paliperidone—Shock—Hydrocortisone—ulcerative colitis	0.000202	0.000503	CcSEcCtD
Paliperidone—Myalgia—Triamcinolone—ulcerative colitis	0.000202	0.000502	CcSEcCtD
Paliperidone—Vomiting—Azathioprine—ulcerative colitis	0.000202	0.000502	CcSEcCtD
Paliperidone—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000202	0.000501	CcSEcCtD
Paliperidone—Arthralgia—Methylprednisolone—ulcerative colitis	0.000202	0.000501	CcSEcCtD
Paliperidone—Myalgia—Methylprednisolone—ulcerative colitis	0.000202	0.000501	CcSEcCtD
Paliperidone—Eye disorder—Prednisone—ulcerative colitis	0.000201	0.0005	CcSEcCtD
Paliperidone—Anxiety—Methylprednisolone—ulcerative colitis	0.000201	0.000499	CcSEcCtD
Paliperidone—Tachycardia—Hydrocortisone—ulcerative colitis	0.000201	0.000499	CcSEcCtD
Paliperidone—Rash—Azathioprine—ulcerative colitis	0.0002	0.000498	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.0002	0.000498	CcSEcCtD
Paliperidone—Dermatitis—Azathioprine—ulcerative colitis	0.0002	0.000497	CcSEcCtD
Paliperidone—Flushing—Prednisone—ulcerative colitis	0.0002	0.000497	CcSEcCtD
Paliperidone—Skin disorder—Hydrocortisone—ulcerative colitis	0.0002	0.000497	CcSEcCtD
Paliperidone—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.0002	0.000497	CcSEcCtD
Paliperidone—Ill-defined disorder—Betamethasone—ulcerative colitis	0.0002	0.000497	CcSEcCtD
Paliperidone—Discomfort—Triamcinolone—ulcerative colitis	0.0002	0.000496	CcSEcCtD
Paliperidone—Discomfort—Methylprednisolone—ulcerative colitis	0.000199	0.000495	CcSEcCtD
Paliperidone—Headache—Azathioprine—ulcerative colitis	0.000199	0.000494	CcSEcCtD
Paliperidone—Diarrhoea—Mesalazine—ulcerative colitis	0.000198	0.000492	CcSEcCtD
Paliperidone—Dry mouth—Triamcinolone—ulcerative colitis	0.000198	0.000491	CcSEcCtD
Paliperidone—Angioedema—Betamethasone—ulcerative colitis	0.000197	0.000489	CcSEcCtD
Paliperidone—Angioedema—Dexamethasone—ulcerative colitis	0.000197	0.000489	CcSEcCtD
Paliperidone—Anorexia—Hydrocortisone—ulcerative colitis	0.000196	0.000487	CcSEcCtD
Paliperidone—Angiopathy—Prednisone—ulcerative colitis	0.000195	0.000486	CcSEcCtD
Paliperidone—Confusional state—Methylprednisolone—ulcerative colitis	0.000195	0.000484	CcSEcCtD
Paliperidone—Immune system disorder—Prednisone—ulcerative colitis	0.000195	0.000484	CcSEcCtD
Paliperidone—Malaise—Dexamethasone—ulcerative colitis	0.000194	0.000483	CcSEcCtD
Paliperidone—Malaise—Betamethasone—ulcerative colitis	0.000194	0.000483	CcSEcCtD
Paliperidone—Oedema—Triamcinolone—ulcerative colitis	0.000194	0.000481	CcSEcCtD
Paliperidone—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000194	0.000481	CcSEcCtD
Paliperidone—Vertigo—Dexamethasone—ulcerative colitis	0.000193	0.000481	CcSEcCtD
Paliperidone—Vertigo—Betamethasone—ulcerative colitis	0.000193	0.000481	CcSEcCtD
Paliperidone—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000193	0.00048	CcSEcCtD
Paliperidone—Syncope—Betamethasone—ulcerative colitis	0.000193	0.00048	CcSEcCtD
Paliperidone—Syncope—Dexamethasone—ulcerative colitis	0.000193	0.00048	CcSEcCtD
Paliperidone—Infection—Triamcinolone—ulcerative colitis	0.000192	0.000478	CcSEcCtD
Paliperidone—Hypotension—Hydrocortisone—ulcerative colitis	0.000192	0.000478	CcSEcCtD
Paliperidone—Infection—Methylprednisolone—ulcerative colitis	0.000192	0.000477	CcSEcCtD
Paliperidone—Dizziness—Mesalazine—ulcerative colitis	0.000191	0.000475	CcSEcCtD
Paliperidone—Shock—Triamcinolone—ulcerative colitis	0.000191	0.000474	CcSEcCtD
Paliperidone—Insomnia—Prednisolone—ulcerative colitis	0.000191	0.000473	CcSEcCtD
Paliperidone—Alopecia—Prednisone—ulcerative colitis	0.00019	0.000473	CcSEcCtD
Paliperidone—Shock—Methylprednisolone—ulcerative colitis	0.00019	0.000473	CcSEcCtD
Paliperidone—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00019	0.000471	CcSEcCtD
Paliperidone—Loss of consciousness—Betamethasone—ulcerative colitis	0.000189	0.00047	CcSEcCtD
Paliperidone—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000189	0.00047	CcSEcCtD
Paliperidone—Paraesthesia—Prednisolone—ulcerative colitis	0.000189	0.00047	CcSEcCtD
Paliperidone—Tachycardia—Triamcinolone—ulcerative colitis	0.000189	0.00047	CcSEcCtD
Paliperidone—Mental disorder—Prednisone—ulcerative colitis	0.000189	0.000469	CcSEcCtD
Paliperidone—Nausea—Azathioprine—ulcerative colitis	0.000189	0.000469	CcSEcCtD
Paliperidone—Tachycardia—Methylprednisolone—ulcerative colitis	0.000189	0.000469	CcSEcCtD
Paliperidone—Skin disorder—Methylprednisolone—ulcerative colitis	0.000188	0.000467	CcSEcCtD
Paliperidone—Erythema—Prednisone—ulcerative colitis	0.000188	0.000466	CcSEcCtD
Paliperidone—Malnutrition—Prednisone—ulcerative colitis	0.000188	0.000466	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000187	0.000466	CcSEcCtD
Paliperidone—Convulsion—Betamethasone—ulcerative colitis	0.000187	0.000464	CcSEcCtD
Paliperidone—Convulsion—Dexamethasone—ulcerative colitis	0.000187	0.000464	CcSEcCtD
Paliperidone—Insomnia—Hydrocortisone—ulcerative colitis	0.000186	0.000462	CcSEcCtD
Paliperidone—Hypertension—Betamethasone—ulcerative colitis	0.000186	0.000462	CcSEcCtD
Paliperidone—Hypertension—Dexamethasone—ulcerative colitis	0.000186	0.000462	CcSEcCtD
Paliperidone—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000185	0.000459	CcSEcCtD
Paliperidone—Vomiting—Mesalazine—ulcerative colitis	0.000184	0.000457	CcSEcCtD
Paliperidone—Myalgia—Betamethasone—ulcerative colitis	0.000183	0.000456	CcSEcCtD
Paliperidone—Myalgia—Dexamethasone—ulcerative colitis	0.000183	0.000456	CcSEcCtD
Paliperidone—Anxiety—Betamethasone—ulcerative colitis	0.000183	0.000454	CcSEcCtD
Paliperidone—Anxiety—Dexamethasone—ulcerative colitis	0.000183	0.000454	CcSEcCtD
Paliperidone—Rash—Mesalazine—ulcerative colitis	0.000182	0.000453	CcSEcCtD
Paliperidone—Dermatitis—Mesalazine—ulcerative colitis	0.000182	0.000453	CcSEcCtD
Paliperidone—Headache—Mesalazine—ulcerative colitis	0.000181	0.00045	CcSEcCtD
Paliperidone—Discomfort—Dexamethasone—ulcerative colitis	0.000181	0.00045	CcSEcCtD
Paliperidone—Discomfort—Betamethasone—ulcerative colitis	0.000181	0.00045	CcSEcCtD
Paliperidone—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000181	0.00045	CcSEcCtD
Paliperidone—Hypotension—Methylprednisolone—ulcerative colitis	0.000181	0.000449	CcSEcCtD
Paliperidone—Pain—Prednisolone—ulcerative colitis	0.00018	0.000448	CcSEcCtD
Paliperidone—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000179	0.000444	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000178	0.000441	CcSEcCtD
Paliperidone—Fatigue—Hydrocortisone—ulcerative colitis	0.000177	0.000441	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—ulcerative colitis	0.000177	0.000439	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000176	0.000439	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000176	0.000438	CcSEcCtD
Paliperidone—Pain—Hydrocortisone—ulcerative colitis	0.000176	0.000437	CcSEcCtD
Paliperidone—Oedema—Betamethasone—ulcerative colitis	0.000176	0.000437	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—ulcerative colitis	0.000176	0.000437	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000176	0.000437	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000176	0.000437	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—ulcerative colitis	0.000175	0.000435	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—ulcerative colitis	0.000175	0.000434	CcSEcCtD
Paliperidone—Infection—Dexamethasone—ulcerative colitis	0.000175	0.000434	CcSEcCtD
Paliperidone—Infection—Betamethasone—ulcerative colitis	0.000175	0.000434	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—ulcerative colitis	0.000174	0.000432	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—ulcerative colitis	0.000174	0.000432	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—ulcerative colitis	0.000174	0.000431	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000174	0.000431	CcSEcCtD
Paliperidone—Anaemia—Prednisone—ulcerative colitis	0.000173	0.000431	CcSEcCtD
Paliperidone—Shock—Dexamethasone—ulcerative colitis	0.000173	0.00043	CcSEcCtD
Paliperidone—Shock—Betamethasone—ulcerative colitis	0.000173	0.00043	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—ulcerative colitis	0.000173	0.000429	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000172	0.000428	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—ulcerative colitis	0.000172	0.000428	CcSEcCtD
Paliperidone—Agitation—Prednisone—ulcerative colitis	0.000172	0.000428	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000172	0.000428	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000172	0.000428	CcSEcCtD
Paliperidone—Nausea—Mesalazine—ulcerative colitis	0.000172	0.000427	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—ulcerative colitis	0.000172	0.000426	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—ulcerative colitis	0.000172	0.000426	CcSEcCtD
Paliperidone—Angioedema—Prednisone—ulcerative colitis	0.000171	0.000426	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—ulcerative colitis	0.000171	0.000424	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00017	0.000423	CcSEcCtD
Paliperidone—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00017	0.000421	CcSEcCtD
Paliperidone—Malaise—Prednisone—ulcerative colitis	0.000169	0.00042	CcSEcCtD
Paliperidone—Vertigo—Prednisone—ulcerative colitis	0.000169	0.000419	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000168	0.000418	CcSEcCtD
Paliperidone—Syncope—Prednisone—ulcerative colitis	0.000168	0.000418	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—ulcerative colitis	0.000168	0.000416	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—ulcerative colitis	0.000168	0.000416	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—ulcerative colitis	0.000167	0.000416	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—ulcerative colitis	0.000167	0.000415	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—ulcerative colitis	0.000167	0.000414	CcSEcCtD
Paliperidone—Pain—Triamcinolone—ulcerative colitis	0.000166	0.000412	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—ulcerative colitis	0.000165	0.00041	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—ulcerative colitis	0.000164	0.000408	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—ulcerative colitis	0.000164	0.000408	CcSEcCtD
Paliperidone—Urticaria—Hydrocortisone—ulcerative colitis	0.000163	0.000406	CcSEcCtD
Paliperidone—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000163	0.000404	CcSEcCtD
Paliperidone—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000163	0.000404	CcSEcCtD
Paliperidone—Convulsion—Prednisone—ulcerative colitis	0.000162	0.000404	CcSEcCtD
Paliperidone—Hypertension—Prednisone—ulcerative colitis	0.000162	0.000402	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.00016	0.000398	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.00016	0.000398	CcSEcCtD
Paliperidone—Myalgia—Prednisone—ulcerative colitis	0.00016	0.000397	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—ulcerative colitis	0.00016	0.000397	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—ulcerative colitis	0.00016	0.000397	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000159	0.000396	CcSEcCtD
Paliperidone—Anxiety—Prednisone—ulcerative colitis	0.000159	0.000395	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—ulcerative colitis	0.000159	0.000395	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—ulcerative colitis	0.000159	0.000395	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000159	0.000394	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000158	0.000393	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—ulcerative colitis	0.000158	0.000392	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—ulcerative colitis	0.000158	0.000392	CcSEcCtD
Paliperidone—Discomfort—Prednisone—ulcerative colitis	0.000158	0.000392	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—ulcerative colitis	0.000155	0.000386	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—ulcerative colitis	0.000155	0.000384	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—ulcerative colitis	0.000155	0.000384	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—ulcerative colitis	0.000154	0.000382	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—ulcerative colitis	0.000154	0.000382	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—ulcerative colitis	0.000153	0.000381	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—ulcerative colitis	0.000153	0.00038	CcSEcCtD
Paliperidone—Oedema—Prednisone—ulcerative colitis	0.000153	0.00038	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000153	0.00038	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—ulcerative colitis	0.000153	0.00038	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—ulcerative colitis	0.000153	0.00038	CcSEcCtD
Paliperidone—Infection—Prednisone—ulcerative colitis	0.000152	0.000378	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000152	0.000377	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000152	0.000377	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000152	0.000377	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—ulcerative colitis	0.000152	0.000377	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—ulcerative colitis	0.000152	0.000377	CcSEcCtD
Paliperidone—Shock—Prednisone—ulcerative colitis	0.000151	0.000374	CcSEcCtD
Paliperidone—Pain—Betamethasone—ulcerative colitis	0.00015	0.000373	CcSEcCtD
Paliperidone—Pain—Dexamethasone—ulcerative colitis	0.00015	0.000373	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—ulcerative colitis	0.00015	0.000373	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—ulcerative colitis	0.000149	0.000371	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—ulcerative colitis	0.000149	0.000369	CcSEcCtD
Paliperidone—Asthenia—Hydrocortisone—ulcerative colitis	0.000148	0.000367	CcSEcCtD
Paliperidone—Anorexia—Prednisone—ulcerative colitis	0.000146	0.000363	CcSEcCtD
Paliperidone—Pruritus—Hydrocortisone—ulcerative colitis	0.000146	0.000362	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—ulcerative colitis	0.000145	0.00036	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000145	0.00036	CcSEcCtD
Paliperidone—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000144	0.000357	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000144	0.000357	CcSEcCtD
Paliperidone—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000143	0.000355	CcSEcCtD
Paliperidone—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000142	0.000354	CcSEcCtD
Paliperidone—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000141	0.00035	CcSEcCtD
Paliperidone—Urticaria—Betamethasone—ulcerative colitis	0.00014	0.000347	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—ulcerative colitis	0.00014	0.000347	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000139	0.000347	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—ulcerative colitis	0.000139	0.000346	CcSEcCtD
Paliperidone—Asthenia—Triamcinolone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—ulcerative colitis	0.000139	0.000345	CcSEcCtD
Paliperidone—Insomnia—Prednisone—ulcerative colitis	0.000138	0.000344	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—ulcerative colitis	0.000137	0.000342	CcSEcCtD
Paliperidone—Pruritus—Triamcinolone—ulcerative colitis	0.000137	0.000341	CcSEcCtD
Paliperidone—Pruritus—Methylprednisolone—ulcerative colitis	0.000137	0.00034	CcSEcCtD
Paliperidone—Dizziness—Hydrocortisone—ulcerative colitis	0.000136	0.000338	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—ulcerative colitis	0.000135	0.000335	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—ulcerative colitis	0.000133	0.000331	CcSEcCtD
Paliperidone—Rash—Prednisolone—ulcerative colitis	0.000133	0.00033	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—ulcerative colitis	0.000133	0.00033	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000132	0.000329	CcSEcCtD
Paliperidone—Fatigue—Prednisone—ulcerative colitis	0.000132	0.000328	CcSEcCtD
Paliperidone—Headache—Prednisolone—ulcerative colitis	0.000132	0.000328	CcSEcCtD
Paliperidone—Constipation—Prednisone—ulcerative colitis	0.000131	0.000325	CcSEcCtD
Paliperidone—Vomiting—Hydrocortisone—ulcerative colitis	0.000131	0.000325	CcSEcCtD
Paliperidone—Rash—Hydrocortisone—ulcerative colitis	0.00013	0.000322	CcSEcCtD
Paliperidone—Dermatitis—Hydrocortisone—ulcerative colitis	0.00013	0.000322	CcSEcCtD
Paliperidone—Headache—Hydrocortisone—ulcerative colitis	0.000129	0.00032	CcSEcCtD
Paliperidone—Dizziness—Triamcinolone—ulcerative colitis	0.000128	0.000318	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—ulcerative colitis	0.000128	0.000318	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—ulcerative colitis	0.000126	0.000313	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—ulcerative colitis	0.000126	0.000313	CcSEcCtD
Paliperidone—Asthenia—Dexamethasone—ulcerative colitis	0.000126	0.000313	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000125	0.000311	CcSEcCtD
Paliperidone—Nausea—Prednisolone—ulcerative colitis	0.000125	0.000311	CcSEcCtD
Paliperidone—Pruritus—Dexamethasone—ulcerative colitis	0.000124	0.000309	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—ulcerative colitis	0.000124	0.000309	CcSEcCtD
Paliperidone—Vomiting—Triamcinolone—ulcerative colitis	0.000123	0.000306	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—ulcerative colitis	0.000123	0.000305	CcSEcCtD
Paliperidone—Nausea—Hydrocortisone—ulcerative colitis	0.000122	0.000304	CcSEcCtD
Paliperidone—Rash—Triamcinolone—ulcerative colitis	0.000122	0.000304	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—ulcerative colitis	0.000122	0.000303	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—ulcerative colitis	0.000122	0.000303	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—ulcerative colitis	0.000122	0.000303	CcSEcCtD
Paliperidone—Urticaria—Prednisone—ulcerative colitis	0.000122	0.000302	CcSEcCtD
Paliperidone—Headache—Triamcinolone—ulcerative colitis	0.000121	0.000302	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—ulcerative colitis	0.000121	0.000301	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—ulcerative colitis	0.000121	0.000301	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—ulcerative colitis	0.000121	0.000301	CcSEcCtD
Paliperidone—Diarrhoea—Betamethasone—ulcerative colitis	0.00012	0.000299	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—ulcerative colitis	0.00012	0.000299	CcSEcCtD
Paliperidone—HTR2A—enteric nervous system—ulcerative colitis	0.000118	0.345	CbGeAlD
Paliperidone—Dizziness—Dexamethasone—ulcerative colitis	0.000116	0.000289	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—ulcerative colitis	0.000116	0.000289	CcSEcCtD
Paliperidone—Nausea—Triamcinolone—ulcerative colitis	0.000115	0.000286	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—ulcerative colitis	0.000115	0.000285	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—ulcerative colitis	0.000113	0.00028	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—ulcerative colitis	0.000112	0.000278	CcSEcCtD
Paliperidone—Vomiting—Betamethasone—ulcerative colitis	0.000112	0.000278	CcSEcCtD
Paliperidone—Rash—Dexamethasone—ulcerative colitis	0.000111	0.000275	CcSEcCtD
Paliperidone—Rash—Betamethasone—ulcerative colitis	0.000111	0.000275	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—ulcerative colitis	0.000111	0.000275	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—ulcerative colitis	0.000111	0.000275	CcSEcCtD
Paliperidone—Headache—Dexamethasone—ulcerative colitis	0.00011	0.000274	CcSEcCtD
Paliperidone—Headache—Betamethasone—ulcerative colitis	0.00011	0.000274	CcSEcCtD
Paliperidone—Asthenia—Prednisone—ulcerative colitis	0.00011	0.000273	CcSEcCtD
Paliperidone—Pruritus—Prednisone—ulcerative colitis	0.000108	0.000269	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—ulcerative colitis	0.000105	0.00026	CcSEcCtD
Paliperidone—Nausea—Dexamethasone—ulcerative colitis	0.000104	0.000259	CcSEcCtD
Paliperidone—Nausea—Betamethasone—ulcerative colitis	0.000104	0.000259	CcSEcCtD
Paliperidone—Dizziness—Prednisone—ulcerative colitis	0.000101	0.000252	CcSEcCtD
Paliperidone—Vomiting—Prednisone—ulcerative colitis	9.73e-05	0.000242	CcSEcCtD
Paliperidone—Rash—Prednisone—ulcerative colitis	9.65e-05	0.00024	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—ulcerative colitis	9.64e-05	0.00024	CcSEcCtD
Paliperidone—Headache—Prednisone—ulcerative colitis	9.59e-05	0.000238	CcSEcCtD
Paliperidone—Nausea—Prednisone—ulcerative colitis	9.09e-05	0.000226	CcSEcCtD
Paliperidone—HTR2A—myenteric nerve plexus—ulcerative colitis	8.98e-05	0.262	CbGeAlD
Paliperidone—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	2.21e-05	0.000135	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	2.2e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ABCB1—ulcerative colitis	2.2e-05	0.000135	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	2.2e-05	0.000135	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	2.19e-05	0.000135	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—JAK2—ulcerative colitis	2.19e-05	0.000134	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	2.19e-05	0.000134	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	2.18e-05	0.000134	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TP53—ulcerative colitis	2.18e-05	0.000134	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	2.18e-05	0.000134	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	2.17e-05	0.000133	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	2.15e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	2.15e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	2.14e-05	0.000132	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	2.11e-05	0.00013	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	2.11e-05	0.000129	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	2.1e-05	0.000129	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	2.09e-05	0.000129	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	2.08e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	2.08e-05	0.000128	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ADCY5—ulcerative colitis	2.05e-05	0.000126	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS1—ulcerative colitis	2.05e-05	0.000126	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	2.04e-05	0.000125	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	2.04e-05	0.000125	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	2.02e-05	0.000124	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	2.02e-05	0.000124	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ABCB1—ulcerative colitis	2.02e-05	0.000124	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	2.01e-05	0.000123	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	2e-05	0.000123	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	2e-05	0.000123	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	2e-05	0.000123	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CXCL8—ulcerative colitis	2e-05	0.000123	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	2e-05	0.000123	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	1.99e-05	0.000122	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—JAK2—ulcerative colitis	1.99e-05	0.000122	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.96e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	1.95e-05	0.00012	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	1.95e-05	0.000119	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	1.95e-05	0.000119	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	1.92e-05	0.000118	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	1.92e-05	0.000118	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	1.91e-05	0.000117	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—IL2—ulcerative colitis	1.91e-05	0.000117	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	1.89e-05	0.000116	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PPARG—ulcerative colitis	1.89e-05	0.000116	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ADCY5—ulcerative colitis	1.88e-05	0.000116	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.88e-05	0.000116	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	1.87e-05	0.000115	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	1.85e-05	0.000113	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	1.85e-05	0.000113	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.85e-05	0.000113	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	1.83e-05	0.000112	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.82e-05	0.000112	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.82e-05	0.000112	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	1.81e-05	0.000111	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	1.81e-05	0.000111	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	1.79e-05	0.00011	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	1.78e-05	0.000109	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—ulcerative colitis	1.77e-05	0.000109	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—RELA—ulcerative colitis	1.77e-05	0.000109	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL2—ulcerative colitis	1.77e-05	0.000108	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—JAK2—ulcerative colitis	1.76e-05	0.000108	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	1.74e-05	0.000107	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	1.74e-05	0.000107	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL2—ulcerative colitis	1.73e-05	0.000106	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—RELA—ulcerative colitis	1.73e-05	0.000106	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	1.72e-05	0.000105	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—RELA—ulcerative colitis	1.7e-05	0.000105	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	1.7e-05	0.000104	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—ulcerative colitis	1.7e-05	0.000104	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	1.67e-05	0.000102	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.65e-05	0.000102	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	1.63e-05	0.0001	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL8—ulcerative colitis	1.61e-05	9.86e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—ulcerative colitis	1.59e-05	9.78e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	1.59e-05	9.73e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—JAK2—ulcerative colitis	1.58e-05	9.73e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	1.58e-05	9.71e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—JAK2—ulcerative colitis	1.56e-05	9.6e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—ulcerative colitis	1.56e-05	9.58e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	1.55e-05	9.53e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—ulcerative colitis	1.54e-05	9.42e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—RELA—ulcerative colitis	1.53e-05	9.42e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—ulcerative colitis	1.53e-05	9.4e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—ulcerative colitis	1.53e-05	9.38e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—RELA—ulcerative colitis	1.51e-05	9.29e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	1.51e-05	9.26e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	1.49e-05	9.16e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—ulcerative colitis	1.48e-05	9.11e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	1.48e-05	9.06e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	1.46e-05	8.97e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MMP9—ulcerative colitis	1.45e-05	8.92e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	1.45e-05	8.88e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NFKB1—ulcerative colitis	1.44e-05	8.82e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.43e-05	8.81e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	1.43e-05	8.76e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	1.41e-05	8.66e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.4e-05	8.62e-05	CbGpPWpGaD
Paliperidone—ADRA1A—epithelium—ulcerative colitis	1.38e-05	0.0403	CbGeAlD
Paliperidone—DRD1—Signaling Pathways—IL2—ulcerative colitis	1.38e-05	8.48e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—ulcerative colitis	1.38e-05	8.46e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—ulcerative colitis	1.38e-05	8.44e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	1.37e-05	8.39e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—ulcerative colitis	1.36e-05	8.37e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	1.36e-05	8.36e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—ulcerative colitis	1.36e-05	8.33e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	1.36e-05	8.32e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	1.34e-05	8.23e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.34e-05	8.22e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.34e-05	8.22e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—RELA—ulcerative colitis	1.32e-05	8.1e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	1.32e-05	8.09e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	1.31e-05	8.06e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—RELA—ulcerative colitis	1.31e-05	8.06e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MMP9—ulcerative colitis	1.31e-05	8.03e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	1.3e-05	7.96e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	1.29e-05	7.94e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—STAT3—ulcerative colitis	1.29e-05	7.93e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MMP9—ulcerative colitis	1.29e-05	7.92e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	1.29e-05	7.91e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	1.28e-05	7.84e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	1.28e-05	7.84e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—ulcerative colitis	1.26e-05	7.75e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	1.26e-05	7.71e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	1.24e-05	7.63e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	1.24e-05	7.63e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	1.24e-05	7.59e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	1.23e-05	7.56e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	1.22e-05	7.52e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	1.22e-05	7.47e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.21e-05	7.4e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—ulcerative colitis	1.21e-05	7.4e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	1.2e-05	7.39e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—ulcerative colitis	1.2e-05	7.35e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—JAK2—ulcerative colitis	1.2e-05	7.34e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—ulcerative colitis	1.19e-05	7.29e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	1.18e-05	7.27e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	1.18e-05	7.26e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—ulcerative colitis	1.18e-05	7.26e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	1.18e-05	7.22e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	1.18e-05	7.22e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JAK2—ulcerative colitis	1.17e-05	7.21e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	1.17e-05	7.15e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—STAT3—ulcerative colitis	1.16e-05	7.14e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RELA—ulcerative colitis	1.16e-05	7.11e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	1.15e-05	7.08e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	1.15e-05	7.07e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	1.15e-05	7.06e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—STAT3—ulcerative colitis	1.15e-05	7.04e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	1.14e-05	7.02e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RELA—ulcerative colitis	1.14e-05	7e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RELA—ulcerative colitis	1.14e-05	6.98e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	1.13e-05	6.95e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	1.13e-05	6.91e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	1.12e-05	6.9e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	1.12e-05	6.87e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	1.12e-05	6.85e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	1.11e-05	6.83e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	1.11e-05	6.8e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—ulcerative colitis	1.1e-05	6.78e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	1.09e-05	6.7e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	1.09e-05	6.68e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	1.08e-05	6.62e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	1.08e-05	6.61e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	1.07e-05	6.59e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	1.07e-05	6.58e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	1.07e-05	6.57e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	1.07e-05	6.57e-05	CbGpPWpGaD
Paliperidone—HRH1—epithelium—ulcerative colitis	1.07e-05	0.0312	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—ulcerative colitis	1.06e-05	0.031	CbGeAlD
Paliperidone—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	1.06e-05	6.53e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	1.06e-05	6.5e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	1.05e-05	6.46e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—ulcerative colitis	1.04e-05	6.4e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—ulcerative colitis	1.04e-05	6.37e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	1.04e-05	6.37e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	1.04e-05	6.36e-05	CbGpPWpGaD
Paliperidone—HRH1—smooth muscle tissue—ulcerative colitis	1.03e-05	0.0301	CbGeAlD
Paliperidone—HTR2A—Signaling Pathways—IL2—ulcerative colitis	1.03e-05	6.3e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—ulcerative colitis	1.02e-05	6.29e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—ulcerative colitis	1.02e-05	6.28e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	1.02e-05	6.27e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—ulcerative colitis	1.02e-05	6.26e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	1.01e-05	6.17e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—ulcerative colitis	1e-05	6.15e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	1e-05	6.14e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	1e-05	6.14e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—ulcerative colitis	9.98e-06	6.13e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	9.95e-06	6.11e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—ulcerative colitis	9.88e-06	6.06e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—ulcerative colitis	9.86e-06	6.05e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	9.77e-06	6e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	9.77e-06	6e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	9.72e-06	5.96e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—ulcerative colitis	9.7e-06	5.95e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	9.68e-06	5.94e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	9.61e-06	5.9e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	9.6e-06	5.89e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	9.59e-06	5.89e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	9.52e-06	5.85e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	9.51e-06	5.84e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	9.41e-06	5.78e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	9.38e-06	5.76e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—ulcerative colitis	9.36e-06	5.75e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	9.34e-06	5.73e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	9.29e-06	5.7e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	9.27e-06	5.69e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	9.22e-06	5.66e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—ulcerative colitis	9.17e-06	5.63e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—ulcerative colitis	9.02e-06	5.54e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—ulcerative colitis	8.98e-06	5.51e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	8.97e-06	5.51e-05	CbGpPWpGaD
Paliperidone—HTR2A—epithelium—ulcerative colitis	8.94e-06	0.0261	CbGeAlD
Paliperidone—DRD1—Signaling Pathways—TP53—ulcerative colitis	8.87e-06	5.45e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	8.84e-06	5.43e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	8.83e-06	5.42e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—ulcerative colitis	8.78e-06	5.39e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—ulcerative colitis	8.76e-06	5.37e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	8.75e-06	5.37e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	8.75e-06	5.37e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	8.64e-06	5.3e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—ulcerative colitis	8.62e-06	5.29e-05	CbGpPWpGaD
Paliperidone—HTR2A—smooth muscle tissue—ulcerative colitis	8.61e-06	0.0251	CbGeAlD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	8.46e-06	5.19e-05	CbGpPWpGaD
Paliperidone—CYP3A5—digestive system—ulcerative colitis	8.39e-06	0.0245	CbGeAlD
Paliperidone—HRH1—digestive system—ulcerative colitis	8.14e-06	0.0237	CbGeAlD
Paliperidone—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	8.14e-06	5e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—ulcerative colitis	8.12e-06	4.99e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—ulcerative colitis	8.01e-06	4.92e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	8.01e-06	4.92e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	7.99e-06	4.9e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	7.91e-06	4.85e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	7.86e-06	4.82e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—ulcerative colitis	7.85e-06	4.82e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	7.84e-06	4.81e-05	CbGpPWpGaD
Paliperidone—ADRA1A—liver—ulcerative colitis	7.84e-06	0.0228	CbGeAlD
Paliperidone—HTR1A—Signaling Pathways—TP53—ulcerative colitis	7.63e-06	4.68e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—ulcerative colitis	7.59e-06	4.66e-05	CbGpPWpGaD
Paliperidone—ADRA2C—liver—ulcerative colitis	7.47e-06	0.0218	CbGeAlD
Paliperidone—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	7.38e-06	4.53e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	7.29e-06	4.47e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	7.27e-06	4.46e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	7.24e-06	4.44e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—ulcerative colitis	6.99e-06	4.29e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—ulcerative colitis	6.95e-06	4.27e-05	CbGpPWpGaD
Paliperidone—HTR2A—digestive system—ulcerative colitis	6.8e-06	0.0198	CbGeAlD
Paliperidone—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	6.76e-06	4.15e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—ulcerative colitis	6.7e-06	4.11e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	6.65e-06	4.08e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—ulcerative colitis	6.59e-06	4.05e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—ulcerative colitis	6.58e-06	4.04e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—ulcerative colitis	6.53e-06	4.01e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	6.46e-06	3.96e-05	CbGpPWpGaD
Paliperidone—CYP3A4—digestive system—ulcerative colitis	6.3e-06	0.0184	CbGeAlD
Paliperidone—CYP3A5—liver—ulcerative colitis	6.25e-06	0.0182	CbGeAlD
Paliperidone—CYP2D6—digestive system—ulcerative colitis	6.19e-06	0.0181	CbGeAlD
Paliperidone—DRD2—Signaling Pathways—IL6—ulcerative colitis	6.13e-06	3.76e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—ulcerative colitis	6.03e-06	3.7e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—ulcerative colitis	6.02e-06	3.7e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	6e-06	3.68e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	5.91e-06	3.63e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—ulcerative colitis	5.87e-06	3.6e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	5.49e-06	3.37e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.13e-06	3.15e-05	CbGpPWpGaD
Paliperidone—HTR2A—liver—ulcerative colitis	5.07e-06	0.0148	CbGeAlD
Paliperidone—CYP3A4—liver—ulcerative colitis	4.69e-06	0.0137	CbGeAlD
Paliperidone—CYP2D6—liver—ulcerative colitis	4.62e-06	0.0135	CbGeAlD
